US equities
|
SPCX
$174.83
▲+2.19%
NVDA
$242.20
▲+1.38%
MU
$1,065.12
▲+0.11%
MRVL
$290.15
▲+6.97%
AMD
$650.56
▲+2.98%
SNDK
$1,674.99
▼-1.71%
AVGO
$376.94
▲+3.98%
TSLA
$380.63
▲+0.50%
SPCX
$174.83
▲+2.19%
NVDA
$242.20
▲+1.38%
MU
$1,065.12
▲+0.11%
MRVL
$290.15
▲+6.97%
AMD
$650.56
▲+2.98%
SNDK
$1,674.99
▼-1.71%
AVGO
$376.94
▲+3.98%
TSLA
$380.63
▲+0.50%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Astria Therapeutics
Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare Conference
May 28, 2025
From
Astria Therapeutics
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
May 22, 2025
From
Astria Therapeutics
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2024
From
Astria Therapeutics
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024
From
Astria Therapeutics
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
May 31, 2023
From
Astria Therapeutics
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Presents Additional Data Supporting STAR-0215 Profile as a Long-Acting Preventative Therapy for Hereditary Angioedema at the 2023 American Academy of Allergy, Asthma, and Immunology Annual Meeting
February 24, 2023
From
Astria Therapeutics
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
June 03, 2022
From
Astria Therapeutics
Via
Business Wire
Tickers
ATXS
